Argenx
ARGX
#524
Rank
HK$309.37 B
Marketcap
HK$5,038
Share price
-1.72%
Change (1 day)
64.37%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -HK$32.59

According to Argenx 's latest financial reports the company's current EPS (TTM) is -HK$32.41. In 2022 the company made an earnings per share (EPS) of -HK$102.21.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$32.59-68.12%
2022-HK$102.21